Protara Therapeutics (TARA) Notes Payables (2013 - 2020)

Protara Therapeutics (TARA) posted quarterly Notes Payables of $370793.0 for Q3 2020, down 60.0% quarter-over-quarter from $926983.0 in Q2 2020.

Protara Therapeutics (TARA) Notes Payables (2013 - 2020) Analysis & Trends

Protara Therapeutics (TARA) has reported Notes Payables for 2 consecutive years, with $370793.0 the latest figure, recorded in Q3 2020.

In Q3 2020, Notes Payables changed N/A year-over-year to $370793.0; the TTM figure through Sep 2020 stood at $370793.0 (changed N/A YoY), while the FY2013 annual figure was $1.4 million, changed N/A from the prior year.
Notes Payables retreated to $370793.0 in Q3 2020 per TARA's latest filing, from $926983.0 in the prior quarter.
Across five years, Notes Payables topped out at $1.3 million in Q1 2020 and bottomed at $370793.0 in Q3 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn
10	Protara Therapeutics	234.56 Mn	234.56 Mn	-

Download Data